Di Gong, Weihua Yang, Qing Zhang, Zhentao Zhu, Manman Huang, Gaoen Ma
Journal: Frontiers in endocrinology 2025;16():1438739
PMID: 40309445
INTRODUCTION
Optical coherence tomography angiography (OCTA), a noninvasive imaging technique, is increasingly used in managing ophthalmic diseases like diabetic retinopathy (DR). This review examines OCTA's imaging principles, its utility in detecting DR lesions, and its diagnostic advantages over fundus fluorescein angiography (FFA).
METHODS
We systematically analyzed 75 articles (2015-2024) from the Web of Science Core Collection, focusing on OCTA's technical principles, clinical applications in DR diagnosis, and its use in diabetes mellitus (DM) without DR and prediabetes. The use of artificial intelligence (AI) in OCTA image analysis for DR severity evaluation was investigated.
RESULTS
OCTA effectively identifies DR lesions and detects early vascular abnormalities in DM and prediabetes, surpassing FFA in noninvasiveness and resolution. AI integration enhances OCTA's capability to diagnose, evaluate, and predict DR progression.
DISCUSSION
OCTA offers significant clinical value in early DR detection and monitoring. Its synergy with AI holds promise for refining diagnostic precision and expanding predictive applications, positioning OCTA as a transformative tool in future ophthalmic practice.
Copyright © 2025 Zhang, Gong, Huang, Zhu, Yang and Ma.
© Copyright 2026, Nutrition Evidence
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.